Belgian Cancer Registry: Accelerated Partial Breast Irradiation and Boost

The 'Innovative Radiotherapy Techniques' registration project is an initiative of the 'Rijksinstituut voor ziekte- en invaliditeitsverzekering' (National Institute for Sickness and Invalidity Insurance) (RIZIV/INAMI) in association with the radiotherapy services that use Accelerated Partial Breast Irradiation (APBI) and Boost. The main objective of this registration study and the limited early research funding is to examine the conditions under which and the fee for which innovative radiotherapy techniques will be included in the nomenclature for the medical services. Radiotherapy departments that want to participate in this project must sign the convention that the centre received from the RIZIV/INAMI. By signing this document they agree to treat patients from pre-determined target groups with the innovative radiotherapy techniques cited and also register the necessary clinical data, for a period of four years via temporary research funding. The clinical data must be registered by the radiotherapy service after the treatment in one of the online registration modules specially developed by the Belgian Cancer Registry for this purpose: the APBI and Boost module.‘创新放射治疗技术登记项目’由国家疾病与伤残保险研究院（荷兰语原名：Rijksinstituut voor ziekte- en invaliditeitsverzekering，英文全称为National Institute for Sickness and Invalidity Insurance，缩写为RIZIV/INAMI）联合开展加速局部乳房放疗（Accelerated Partial Breast Irradiation，APBI）与推量放疗（Boost）服务的放射治疗机构共同发起。 本次登记研究及配套的有限早期研究经费，其核心目标为明确创新放射治疗技术纳入医疗服务术语命名体系的适用条件与收费标准。 有意参与本项目的放射治疗科室，需签署由RIZIV/INAMI向其所在机构发放的合作协议。签署该协议后，科室承诺将在为期四年的临时研究经费周期内，采用前述创新放射治疗技术为预先划定的目标人群患者提供诊疗服务，并同步登记必要的临床数据。临床数据需由放射治疗服务机构在患者治疗结束后，通过比利时癌症登记处（Belgian Cancer Registry）专为该项目开发的APBI与Boost两款在线登记模块完成填报。